Florida Cancer Specialists & Research Institute | Strategic Alliance Partners

Central Florida Cancer Care Center/Radiation Oncology Consultants Joins Statewide Practice.

Trilaciclib is the first FDA-approved therapy in its class to help protect bone marrow cells from damage caused by chemotherapy.

Physicians can make an exact diagnosis and prognosis and plan treatment that targets a specific tumor with great precision.

Are smoothies as good as actually eating those fruits and vegetables?

Swift treatment can improve cancer survival rates.

FCS announced a partnership with IDEOology Health to serve as the exclusive provider of multi-channel medical education for the providers within the statewide practice.

Drug shortages are a common issue in the health care industry. Florida Cancer Specialists & Research Institute (FCS) is highly skilled at proactively managing the drug supplies it needs to care for patients.

Advanced precision system protects heart during treatment for breast and lung cancer.

Blasini joined FCS in 2012 as a hematopathologist and has served as co-director of the Pathology Laboratory since 2018.

Florida Cancer Specialists & Research Institute demands change and encourages legislative action.

Ana Van Der Wall, MD reflects on her mother’s influence on her choice to become a medical oncologist.

Florida Cancer Specialists & Research Institute, LLC (FCS) has expanded its efforts to create value for patients by working closely with the payer community.

FCS president and managing physician Lucio Gordan, MD, is a featured speaker at nationwide oncology event to discuss how genetics are advancing cancer care.

FCS opened a new clinic in Clermont with a ribbon-cutting ceremony on Thursday, April 27, 2023.

Two Board-certified medical oncologists, Elena Kruglyak, MD, and Samarth L. Reddy, MD, have joined FLS at the Delray clinic in Palm Beach County.

A case study details the evolution of a new first-line therapy.

Florida Cancer Specialists & Research Institute leads discussions on cancer care challenges at 2023 FLASCO Business of Oncology Summit & Spring Session.

Florida Cancer Specialists & Research Institute medical oncologist Barry Berman, MD, MS, serves on the ASCO Anxiety & Depression Update Expert Panel.

Study authors determined that prevention or mitigation of myelotoxic events that destroy bone marrow can potentially lessen myelosuppression in patients with ES-SCLC.

Cross-disciplinary team promotes comprehensive, innovative cancer diagnosis and treatment options.

Refreshed platform serves as a critical foundation for the future of FCS

Designation demonstrates highest level of commitment to quality healthcare.

Florida Cancer Specialists & Research Institute’s Chief Executive Officer supports the organization's focus on rebranding disability through achievement.